Syntax Research, Inc.
Source: SEC Form 13F · as of Mar 2026Syntax Research, Inc. holds 13 biotech & pharma companies tracked by BioSniper, totaling $2.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
13
Total value held
$2.1M
| Company | Shares | Value |
|---|---|---|
| ABTABBOTT LABORATORIES | 12,000 | $1.2M |
| REGNREGENERON PHARMACEUTICALS, INC. | 245 | $189K |
| MRKMerck & Co., Inc. | 1,381 | $166K |
| LLYELI LILLY & Co | 140 | $129K |
| JNJJOHNSON & JOHNSON | 411 | $100K |
| GMEDGlobus Medical Inc. | 1,000 | $86K |
| AMGNAMGEN INC | 237 | $83K |
| ZTSZoetis Inc. | 304 | $36K |
| ELVElevance Health Inc. | 122 | $36K |
| GMOptec International, Inc. | 466 | $35K |
| PFEPFIZER INC | 871 | $24K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 67 | $18K |
| LXRXLEXICON PHARMACEUTICALS, INC. | 142 | $222 |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.